Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester A Mathis

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
Neuroimage. Clinical|December 8, 2015
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjectsJames M Mountz, Charles M Laymon, Ann D Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
Brain : a Journal of Neurology|October 12, 2007
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's diseaseKerryn E Pike, Greg Savage, Victor L Villemagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography coreWilliam J Jagust, Dan Bandy, Kewei Chen, et al.
Nuclear Medicine and Biology|May 31, 2020
Development of a PET radioligand selective for cerebral amyloid angiopathyEric E Abrahamson, Jeffrey S Stehouwer, Alberto L Vazquez, et al.
Neuroimage|January 4, 2011
Inter-rater reliability of manual and automated region-of-interest delineation for PiB PETBedda L Rosario, Lisa A Weissfeld, Charles M Laymon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurementsRebecca L McNamee, Seong-Hwan Yee, Julie C Price, et al.
Synapse (New York, N.Y.)|July 23, 2011
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyRajesh Narendran, Diana Martinez, Neale Scott Mason, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinomaNeale S Mason, Brian J Lopresti, James Ruszkiewicz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?Jitka Sojkova, Lori Beason-Held, Yun Zhou, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Neuroimage. Clinical|December 8, 2015
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjectsJames M Mountz, Charles M Laymon, Ann D Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
Brain : a Journal of Neurology|October 12, 2007
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's diseaseKerryn E Pike, Greg Savage, Victor L Villemagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography coreWilliam J Jagust, Dan Bandy, Kewei Chen, et al.
Nuclear Medicine and Biology|May 31, 2020
Development of a PET radioligand selective for cerebral amyloid angiopathyEric E Abrahamson, Jeffrey S Stehouwer, Alberto L Vazquez, et al.
Neuroimage|January 4, 2011
Inter-rater reliability of manual and automated region-of-interest delineation for PiB PETBedda L Rosario, Lisa A Weissfeld, Charles M Laymon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurementsRebecca L McNamee, Seong-Hwan Yee, Julie C Price, et al.
Synapse (New York, N.Y.)|July 23, 2011
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyRajesh Narendran, Diana Martinez, Neale Scott Mason, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinomaNeale S Mason, Brian J Lopresti, James Ruszkiewicz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?Jitka Sojkova, Lori Beason-Held, Yun Zhou, et al.
Pageof 21